Can Twitter Save MannKind Corporation?
MannKind has plans to use social media to help grow script volume for its inhaled insulin.
Why Halozyme Therapeutics Inc. Rose 76% in 2015
It was a banner year for the human enzyme specialist.
5 Biotech Predictions for 2016
A win and loss for marijuana, a big advance in Alzheimer's disease, and the next big thing are among some of the market-moving things I expect to see happen this year.